SFDA issued a notification on soliciting public comments on several administration provisions, which include Drug Registration Administrative Provisions (Trial), Administrative Provisions for Packaging Materials and Containers Directly Contacting with Drugs, Administrative Measures Regarding the Approval and Licensing of Biological Products. The content subject to revision is mainly the parts that are not in line with Administrative Licensing Law of the People's Republic of China. The comments must be received by Jun. 7, 2004. (2004-05-31)

 

(Unofficial English Translations)